Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRB..L Regulatory News (RB.)

  • There is currently no data for RB.

Board Committee Changes

29 Jul 2016 16:45

RNS Number : 7403F
Reckitt Benckiser Group PLC
29 July 2016
 

29 July 2016

RECKITT BENCKISER GROUP PLC

(The "Company" or "RB")

 

BOARD COMMITTEE CHANGES

 

The Company is pleased to announce the following changes to its standing Board Committees and their membership.

New Corporate Responsibility, Sustainability, Ethics and Compliance Committee

On the recommendation of the Nomination Committee, on 28 July 2016 the Board approved the establishment of a new Board committee to be known as the Corporate Responsibility, Sustainability, Ethics and Compliance Committee ("CRSEC Committee") with immediate effect. This new committee will support the Board in fulfilling its duty to safeguard and advance the Company's reputation for responsible and sustainable corporate conduct by reviewing, monitoring and assessing its approach to and management of corporate social responsibility, environmental and sustainability issues and behaviours, ethical conduct and regulatory compliance.

The CRSEC Committee will be chaired by Pam Kirby, and Adrian Bellamy and Nicandro Durante have been appointed as committee members. The CRSEC Committee will meet at least three times per year and at such other times as required. 

The Committee's terms of reference will be available on the Company's website at www.rb.com

Nomination Committee Membership

The Nomination Committee also recommended, and the Board approved, the appointment of Pam Kirby to the Nomination Committee with immediate effect. 

This disclosure is made in accordance with paragraph 9.6.11 of the Financial Conduct Authority's Listing rules.

 

For further Information:

Chris LoganCompany Secretary+44 (0) 1753 217 800

 

Richard Joyce

SVP, Investor Relations, Communications & External Affairs

+44 (0)1753 217 800

 

 

About RB:

 

RB* is the world's leading consumer health and hygiene company. The company has operations in over 60 countries, with headquarters in London, Dubai and Amsterdam, and sales in most countries across the globe. The company employs approximately c. 37,000 people worldwide.

Inspired by a purpose to deliver innovative solutions for healthier lives and happier homes, RB is in the top 20 companies listed on the London Stock Exchange. We are the global No 1 or No 2 in the majority of our fast-growing categories, driven by an exceptional focus on innovation. Our health, hygiene and home portfolio is led by our global Powerbrands including Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Air Wick, Woolite and French's. Our Powerbrands represent 80% of net revenue.

 

RB is redefining the world of consumer health and hygiene. Our people and unique culture are at the heart of our success. We have a drive for achievement and a passion to outperform wherever we focus, including sustainability where we are targeting a 1/3 reduction in water impact, 1/3 reduction in carbon and 1/3 of net revenue from more sustainable products. We are proud to be Save the Children's largest global partner, with a new vision to radically reduce one of the world's largest killers of under 5s, diarrhoea. 

 

For more information visit www.rb.com

 

*RB is the trading name of the Reckitt Benckiser group of companies

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOASEEFIUFMSELW
Date   Source Headline
5th Mar 20194:30 pmRNSDirector Declaration
4th Mar 201911:43 amRNSDirector/PDMR Shareholding
1st Mar 20197:30 amRNSTotal Voting Rights
28th Feb 201911:16 amRNSDirector/PDMR Shareholding
20th Feb 20193:19 pmRNSDirector/PDMR Shareholding
18th Feb 20197:00 amRNSFull Year Results 2018
1st Feb 20198:44 amRNSTotal Voting Rights
16th Jan 20197:05 amRNSRakesh Kapoor to retire as CEO by end of 2019
4th Jan 201911:00 amRNSDirectorate Change
2nd Jan 20192:23 pmRNSDirectorate Change
31st Dec 20181:12 pmRNSTotal Voting Rights
27th Dec 20184:41 pmRNSSecond Price Monitoring Extn
27th Dec 20184:35 pmRNSPrice Monitoring Extension
13th Dec 20189:43 amRNSDirectorate Change
3rd Dec 201810:09 amRNSTotal Voting Rights
19th Nov 201810:11 amRNSDirector Declaration
9th Nov 201811:56 amRNSDirectorate Change
31st Oct 201812:18 pmRNSDirector/PDMR Shareholding
30th Oct 20187:00 amRNSQ3 2018: Trading Update
1st Oct 20185:17 pmRNSDirector/PDMR Shareholding
1st Oct 201812:34 pmRNSTotal Voting Rights
31st Aug 20184:46 pmRNSTotal Voting Rights
31st Aug 20184:00 pmRNSDirectorate Change
8th Aug 20182:32 pmRNSHolding(s) in Company
1st Aug 20189:43 amRNSTotal Voting Rights
27th Jul 20187:00 amRNSHalf Year Results
2nd Jul 201810:01 amRNSTotal Voting Rights
26th Jun 201810:15 amRNSDirectorate Change
7th Jun 20184:55 pmRNSDirector/PDMR Shareholding
1st Jun 201811:28 amRNSTotal Voting Rights
31st May 20184:35 pmRNSPrice Monitoring Extension
29th May 20183:11 pmRNSDirector/PDMR Shareholding
25th May 20185:34 pmRNSDirector/PDMR Shareholding
9th May 20182:00 pmRNSHolding(s) in Company
8th May 20182:00 pmRNSDirector/PDMR Shareholding
4th May 20184:27 pmRNSDirectorate Change
3rd May 20183:17 pmRNSResult of AGM
1st May 20181:00 pmRNSChange in Director's Details
1st May 20189:30 amRNSTotal Voting Rights
20th Apr 20187:00 amRNSQ1 2018 Trading Update
18th Apr 20182:00 pmRNSHolding(s) in Company
3rd Apr 20189:00 amRNSTotal Voting Rights
28th Mar 20185:23 pmRNSAnnual Financial Report
22nd Mar 20187:00 amRNSOffer Talks Terminated
19th Mar 201811:00 amRNSDirectorate Change
1st Mar 201810:59 amRNSTotal Voting Rights
19th Feb 20187:00 amRNSFinal Results
1st Feb 20189:19 amRNSTotal Voting Rights
2nd Jan 201810:07 amRNSTotal Voting Rights
1st Dec 201710:07 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.